Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study
2019 ◽
Vol 65
(1)
◽
2013 ◽
Vol 62
(5)
◽
pp. 278
◽
2019 ◽
Vol 40
(4)
◽
pp. 629-636
2020 ◽
Vol 5
(01)
◽
pp. 87-97
2017 ◽
Vol 2
(06)
◽
Keyword(s):
2008 ◽
Vol 6
(6)
◽
pp. 360-362
◽